Sell. Leave. Go away. Caveat Emptor. Incessant whining is boring. If you think they mis led to what benefit? No insider sales, no public offering based on alleged pump and dump. Who made money directly related to the Company. Did the Company bring in more funds if they were requiring LPC to buy according to their contract as the price rose? Good. More operating capital per share, less shares in the float. Who pUshed the price up anyhow? Traders on speculation.
Folks would be whining if management didn't put out any target dates. It is science and business. Timelines are just estimates. So they blew it with timing. The announcement was confirming data again based on the old methodology etc showing statistical significance of the idea and proving repeteviness. Don't come whining about sensitivity specicifity undersized/power of the trial etc. They are still working on the product.
If you feel cheated then so be it, but that is your problem for being greedy and not selling as the price increased. Biotechs, especially on OTC are fickle, high risk and dangerous investments. The reward can be awesome. Gerald thought they would get it done, they didn't, the price was punished. If he hadn't put anything out the PPS never would have gone to $.19 in the first
And with a PET scan costs $3500 a pop vs a blood test like Lympro that GC has said it will be 25% of that cost
With a reverse split thrown in. Stop trying to make irrational comparisons and lie through omission of facts.
And how was he breaching Fiduciary Duty by that definition. He is utilizing the assets of the company (cash, IP, ability to raise cash through private placements/contacts) in a prudent way to increase value of the company. Long term the company continues to use its assets to build value which in time has grown the PPS. Where has he not been in line with shareholders? Has he sold? No. Did he buy on the dip? No. So where has he breached fiduciary duty? The fact that the price went down on a poorly executed timeline? If that is the case you better be willing to call every CEO that misses on earnings to the carpet and say that they have breached fiduciary duty since a PPS can take 20% drops on that exact scenario. You can throw the terminology out all you want, but the history bears out no breach. PPS fluctuations in the short term do not reflect the Fiduciary Standard. Maybe a component if over the long term the PPS stagnates and the CEO continues to get massive bonuses and other compensatory measures that are not in line with ROE or performance.
Point out any post where there is materially any incorrect information I have stated that would be considered a bash of this company. The release of the blog yesterday was nothing really new that had not been discussed in the past. Get over yourself and get back under GC's desk.
Of course pumping is being done here. It is plain to see. I just hate the high and mighty who think they have a monopoly on the truth and will set us poor suckers straight. They usually have the greatest agenda of all. We all know that riskreturn, pais, and several others ball wash AMBS on a constant basis and probably do play the swings, contrary to their protests that they don't. I have healthy skepticism as most investors should, but it is quite clear about this particular poster what their angle is.
Did Gerald kick you out of the office this morning and from under his desk and it prompted you to write this?? You are truly a pathetic human being. This is the same kind of stuff that you attack other people for. What a weasel.
I am not a scientist, but if I interpret the definition of longitudinal study correctly, Poster 3 is just an updated observational report on how accurate the original data from 2008 was. In other words, they ran some tests in 2008, made a diagnosis and have now come back to see how they did using that original testing method. In the intervening time frame there have been advances in the testing procedures which have increased accuracy and that is what Poster 1 was indicating and what the Bridging Data will hopefully show between the original work and Lympro 1 and Lympro 2 under the Amarantus custodianship correct?
The fool who posts or the fool who responds to the fool? Put them on ignore. Soon they will go away because no one will engage in their attempts at being self important. They migrate here because they have worn out their welcome in other spots. Let that occur again and the board will be better once again.
It's your job to research a company. Not a CEOs job to hand it out on a silver platter. There are plenty of resources to do that work. You just can't be lazy and depend on others to hand you a free lunch.
Well Mr Expert, what trials have you run? Obviously you know more than the company. Maybe you should go and help them since it is so easy.."
Another douche who shows up throwing around a pile of #$%$ and hoping it sticks to the walls. Amazing how this poster comes out of the shadows now and claims he doesn't care about AMBS, just wants to shed the light of truth on the seedy underbelly of the paid promotion. Right. Everyone has an agenda. His is clear. Put the idiot on ignore and do your own due diligence.